Barish, Robert
Mayo Clinic
From the NAFLD Research Center, Division of Gastroenterology and Hepatology, Department of Medicine, University of California, San Diego, La Jolla (R.L.), Velocity Clinical Research, Los Angeles (J.P.F.), and 89bio, San Francisco (M.D.G., S.F., G.D.A., C.L
Citations 1
Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH
Bhatt, Deepak L. , Alkhouri, Naim , Frías, Juan P. , Lazas, Donald J., Barish, Robert J., Gottwald, Mildred D., Feng, Shibao, Agollah, Germaine D., Hartsfield, Cynthia L., Mansbach, Hank, Margalit, Maya, Loomba, Rohit , Alkhouri, Naim , Frias, Juan P , Bedossa, Pierre, Lazas, Donald, Barish, Robert, Abdelmalek, Manal F. , Bhatt, Deepak L , Loomba, Rohit , Sanyal, Arun J. , Kowdley, Kris V. , Bédossa, Pierre , Harrison, Stephen A. , Barish, Robert
New England Journal of Medicine | June 24, 2023 | Volume: 389 | Issue: 11 | Pages: 998-1008
